Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Other

Acute kidney injury

Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026

Sentiment
0
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Business
Impact: Acute kidney injury (AKI) is the medical condition that Revelation Biosciences's drug candidate Gemini aims to treat, representing a significant unmet medical need that the expanded advisory board will help address.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Acute kidney injury live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.